Abstract
Perimenopause is a complex and dynamic hormonal transition marked by fluctuations in estrogen and progesterone, leading to widespread effects on neuroendocrine function, metabolism, and structural integrity. Unlike menopause, it is not a fixed state but a variable phase that can begin in early midlife and present with symptoms such as mood disturbances, sleep disruption, metabolic changes, and connective tissue decline. These changes are influenced not only by aging but also by cumulative stress, environmental exposures, and overall physiological health.
At the core of perimenopause is dysregulation of the hypothalamic-pituitary-ovarian axis, resulting in inconsistent hormonal signaling that impacts neurotransmitters, metabolic pathways, and systemic function. This contributes to increased inflammation, reduced mitochondrial efficiency, altered glucose regulation, and heightened cardiometabolic risk.
Natural medicine offers a systems-based approach to addressing these changes by targeting key physiological pathways. Nutritional strategies support estrogen metabolism and detoxification, particularly through liver function and the gut microbiome. Botanicals and nutraceuticals play a role in regulating mood, enhancing stress resilience, improving metabolic flexibility, and reducing inflammation. Additional support for structural health, including bone, skin, and connective tissue, is achieved through targeted nutrients such as silica, vitamins, and collagen-supportive compounds.
While hormone replacement therapy remains effective for symptom relief, it does not fully address underlying metabolic and environmental factors and may not be appropriate for all individuals. Natural medicine approaches can serve as either a primary strategy in early perimenopause or as a complementary intervention alongside pharmaceutical care.
Overall, a comprehensive and individualized approach that integrates nutrition, lifestyle, and targeted supplementation provides a more complete framework for supporting hormone health during perimenopause. This model emphasizes long-term health, improved quality of life, and a shift toward preventative, physiology-driven care.
References
- Cione E., et al. “Quercetin, Epigallocatechin Gallate, Curcumin, and Resveratrol: From Dietary Sources to Human MicroRNA Modulation”. Molecules 25.1 (2019): 63.
- Erdélyi A., et al. “The Importance of Nutrition in Menopause and Perimenopause-A Review”. Nutrients 16.1 (2024): 27.
- Ghosh S and Iacucci M. “Diverse Immune Effects of Bovine Colostrum and Benefits in Human Health and Disease”. Nutrients 13.11 (2021): 3798.
- Harak SS., et al. “Navigating Nutrition through the Decades: Tailoring Dietary Strategies to Women’s Life Stages”. Nutrition 135 (2025): 112736.
- Kenda M., et al. “Herbal Products Used in Menopause and for Gynecological Disorders”. Molecules 26.24 (2021): 7421.
- Li C, Liang Y and Qiao Y. “Messengers from the Gut: Gut Microbiota-Derived Metabolites on Host Regulation”. Frontiers in Microbiology 13 (2022): 863407.
- Mishra K and Kakhlon O. “The Crucial Role of NAD+ in Mitochondrial Metabolic Regulation”. BIOCELL 49.7 (2025): 1101-1123.
- Muddapur UM., et al. “Exploring Bioactive Phytochemicals in Gymnema sylvestre: Biomedical Uses and Computational Investigations”. Separations 11.2 (2024): 50.
- Pritchard A and Nielsen BD. “Silicon Supplementation for Bone Health: An Umbrella Review Attempting to Translate from Animals to Humans”. Nutrients 16.3 (2024): 339.
- Sahni S, Lobo-Romero A and Smith T. “Contemporary Non-hormonal Therapies for the Management of Vasomotor Symptoms Associated with Menopause: A Literature Review”. European Endocrinology 17.2 (2021): 133.
- Santoro N., et al. “The Menopause Transition: Signs, Symptoms, and Management Options”. The Journal of Clinical Endocrinology & Metabolism 106.1 (2020): 1-15.
- Shinde S, Singh A, Shinde S and Suresh J. “Emerging Perspectives on Plant-Based L-Dopa Sources for the Treatment of Parkinson’s disease”. 30.2 (2024): 551-559.
- Shrivastava R., et al. “Effects of Flaxseed on Perimenopausal Symptoms: Findings from a Single-Blind, Randomized, Placebo-Controlled Study”. Cureus (2024).
- The North American Menopause Society. “The 2023 nonhormone therapy position statement of The North American Menopause Society”. Menopause 30.6 (2023): 573-590.
- Wang L., et al. “How does the tea L-theanine buffer stress and anxiety”. Food Science and Human Wellness 11.3 (2022): 467-475.
- Webster J., et al. “Nutritional strategies to optimize musculoskeletal health for fall and fracture prevention: Looking beyond calcium, vitamin D and protein”. Bone Reports 19 (2023): 101684.